![LABETALOL HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]](https://medic.hrt.org//dailymed/images/f0a9df5b-45b5-4be5-aeb6-76d0c27a7799/52533-034-20.jpg)
| NDC | 52533-034-20 |
| Set ID | f0a9df5b-45b5-4be5-aeb6-76d0c27a7799 |
| Category | HUMAN PRESCRIPTION DRUG LABEL |
| Packager | Cantrell Drug Company |
| Generic Name | |
| Product Class | beta-Adrenergic Blocker |
| Product Number | |
| Application Number |
- Label
- SPL UNCLASSIFIED SECTION
-
INGREDIENTS AND APPEARANCE
LABETALOL HCL
labetalol hcl injection, solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:52533-034 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LABETALOL HYDROCHLORIDE (UNII: 1GEV3BAW9J) (LABETALOL - UNII:R5H8897N95) LABETALOL HYDROCHLORIDE 5 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Anhydrous Dextrose (UNII: 5SL0G7R0OK) 45 mg in 1 mL Edetate Disodium (UNII: 7FLD91C86K) 0.1 mg in 1 mL Methylparaben (UNII: A2I8C7HI9T) 0.8 mg in 1 mL Propylparaben (UNII: Z8IX2SC1OH) 0.1 mg in 1 mL Citric Acid Monohydrate (UNII: 2968PHW8QP) Sodium Hydroxide (UNII: 55X04QC32I) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52533-034-20 4 mL in 1 SYRINGE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/23/2012 Labeler - Cantrell Drug Company (035545763)
